Blacksmith Medicines

company

About

Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.

  • 11 - 50

Details

Last Funding Type
Seed
Industries
Biotechnology,Genetics,Life Science
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology. Over 30% of known enzymes are metalloenzymes, covering all major enzyme classes: oxidoreductases, transferases, hydrolases, lyases, isomerases, and ligases. Metal ions, including magnesium, zinc, iron, manganese and copper, are the essential ingredient in these metalloenzymes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Blacksmith Medicines has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 8, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 8, 2021 Seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Blacksmith Medicines is funded by 1 investors. Evotec are the most recent investors.
Investor Name Lead Investor Funding Round
Evotec Seed